A study by Michigan Medicine determined how many patients who pass spontaneous breathing trials were extubated within six hours and what factors were associated with staying connected to a ventilator.

A JAMA Internal Medicine looked at two groups of patients treated for COPD and asthma who were switched from budesonide/formoterol (commonly known as Symbicort) to the dry powder inhaler fluticasone/salmeterol. The change was associated with increased steroid use.

Join us for the 37th Annual Update in Pulmonary and Critical Care Medicine Thursday-Friday, November 6-7, 2025, at the Sheraton Hotel in Ann Arbor.

The Advances in the Treatment of Stage III Non-Small Cell Lung Cancer (NSCLC) CME webinar, featuring a panel discussion with Michigan Medicine faculty from hematology and oncology, radiation oncology, pulmonary and critical care medicine, and thoracic surgery, will provide an update on the evolving landscape of NSCLC treatment.

The Respiratory Health Association (RHA) recently named Wassim Labaki, MD, an Assistant Professor of Internal Medicine in the Division of Pulmonary and Critical Care Medicine and a provider in the Michigan Medicine COPD Clinic, the recipient of the 2025 Solovy Award for Advancement in COPD.

Three Medical School faculty members are among a group of 50 nationwide to receive Young Physician-Scientist Awards from the American Society for Clinical Investigation. Nora V. Becker, M.D., Ph.D., an assistant professor of internal medicine in the Division of General Medicine; Wassim Walid Labaki, M.D., M.S., an assistant professor of internal medicine in the Division of Pulmonary and Critical Care Medicine; and John R. Prensner, M.D., Ph.D., an assistant professor of pediatrics and biological chemistry, are recipients of the annual award, which recognizes physician-scientists who are within 1-5 years of their first faculty appointment and have made notable achievements in their research.